HCPCS Level IIdrugActive
J9028
Inj, nogapendekin pmln, 1mcg
BETOS: O1D
Effective: 2025-01-01
Description
Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Anktiva
Manufacturer
Altor BioScience, LLC
HCPCS Dosage
1 MCG
Billing Units
400.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.